Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
Delayed Quote. Delayed Nyse - 10/30 04:10:00 pm
147.49 USD   +2.57%
10/29MCKESSON : Declares Quarterly Dividend
PU
10/29MCKESSON : Declares Quarterly Dividend
BU
10/29MCKESSON CORPORATION : half-yearly earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
152.27(c) 149.21(c) 144.1(c) 143.79(c) 147.49(c) Last
639 646 618 615 920 004 1 012 852 1 125 067 Volume
-2.65% -2.01% -3.42% -0.22% +2.57% Change
More quotes
Financials (USD)
Sales 2021 238 B - -
Net income 2021 2 216 M - -
Net Debt 2021 1 990 M - -
P/E ratio 2021 10,5x
Yield 2021 1,20%
Sales 2022 251 B - -
Net income 2022 2 405 M - -
Net Debt 2022 45,8 M - -
P/E ratio 2022 9,43x
Yield 2022 1,23%
Capitalization 23 321 M 23 321 M -
EV / Sales 2021 0,11x
EV / Sales 2022 0,09x
Nbr of Employees 70 000
Free-Float 59,5%
More Financials
Company
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (90.9%); - distribution of medical and surgical products (3.6%); - other (5.5%): primarily technology services and software sales. The United States account for 83.4% of net sales. 
More about the company
Notations Surperformance© of McKesson Corporation
Trading Rating : Investor Rating :
More Ratings
All news about MCKESSON CORPORATION
10/29MCKESSON : Declares Quarterly Dividend
PU
10/29MCKESSON : Declares Quarterly Dividend
BU
10/29MCKESSON CORPORATION : half-yearly earnings release
10/28MCKESSON : Providing Care in a Pandemic and Beyond, Three Considerations for Hos..
AQ
10/22Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case
DJ
10/22Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case -..
DJ
10/21Pfizer Sets Up Its 'Biggest Ever' Vaccination Distribution Campaign
DJ
10/20MCKESSON : Board of Directors Elects Linda Mantia as New Independent Director
AQ
10/19MCKESSON CORP : Change in Directors or Principal Officers (form 8-K)
AQ
10/19MCKESSON : Board of Directors Elects Linda Mantia as New Independent Director
BU
10/06MCKESSON CORPORATION : to Announce Second Quarter Fiscal 2021 Results on Novembe..
AQ
10/05MCKESSON CORPORATION : to Announce Second Quarter Fiscal 2021 Results on Novembe..
BU
10/05Covid-19 Vaccine Delivery Will Present Tough Challenge to Cargo Airlines
DJ
10/01All Remdesivir Supplies to Be Distributed in U.S. by Maker Gilead Sciences --..
DJ
10/01All Remdesivir Supplies to Be Distributed in U.S. by Maker Gilead Sciences
DJ
More news
News in other languages on MCKESSON CORPORATION
10/29MCKESSON CORPORATION : Veröffentlichung des Halbjahresergebnisses
10/29MCKESSON CORPORATION : publication des résultats semestriels
10/23CRISE DES OPIACÉS : le géant Walmart attaque le ministère américain de la Justic..
07/29MCKESSON CORPORATION : Veröffentlichung des Quartalsergebnisses
07/29MCKESSON CORPORATION : publication des résultats trimestriels
More news
Analyst Recommendations on MCKESSON CORPORATION
More recommendations
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 183,56 $
Last Close Price 143,79 $
Spread / Highest target 46,0%
Spread / Average Target 27,7%
Spread / Lowest Target 4,32%
EPS Revisions
Managers
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Edward A. Mueller Chairman
Britt Vitalone Chief Financial Officer & Executive Vice President
Nancy Flores EVP, Chief Technology & Information Officer
M. Christine Jacobs Independent Director
Sector and Competitors